Stories

Health
An Experimental Drug Targets Alzheimer's Before the First Memory Fades
A drug called NU-9 blocks toxic brain proteins before Alzheimer's symptoms appear, and it could reshape how we think about prevention entirely.
HE
Health
Scientists Find a Metabolic Weak Spot in the Drug-Resistant Fungus Candida auris
A new living-host model let scientists watch Candida auris hunt for nutrients during infection, revealing a potential weak spot in one of medicine's most feared pathogens.

Mobility
Australia's $158M Bet on a GPS-Free Future for Autonomous Vehicles
A Sydney startup just raised $158 million to build navigation that works when GPS fails — and the stakes go far beyond self-driving cars.

Mobility
Suzuki's e-Vitara Bets That Electric and Off-Road Can Coexist
Suzuki's first electric SUV brings genuine off-road hardware to a crowded EV market, but the real test is whether brand identity can survive electrification.

Mobility
The EV Fleet Is Already Reshaping Oil's Strategic Power
The global EV fleet is already displacing oil demand equal to 70% of Iran's exports, quietly rewriting the geopolitics of energy security.

Mobility
Tesla Bets Everything on 500 kW Superchargers as the EV Grid Race Accelerates
Tesla's decision to drop 250 kW hardware and go all-in on 500 kW Supercharger cabinets is quietly setting the standard for the entire EV charging industry.
More Stories

Health
The Blood Flow Fix That Could Reframe How We Treat Dementia

Mobility
Polestar 5's Cradle-to-Gate Carbon Audit Reveals Where EV Emissions Actually Hide
HE
Health
Sudan at 1,000 Days: How a Collapsing Health System Feeds Its Own Disaster

Mobility
Australia's Self-Driving Car Gamble: The Hidden Costs Beneath the Promise
Advertisementinfeed_2

Mobility
BMW's i3 Sedan Promises 900 km of Range — and a New Benchmark for EVs
BMW's new i3 sedan claims 900 km of WLTP range and 400 kW charging — numbers that could redraw the premium EV competitive map.

Health
WHO Warns Weak Drink Taxes Are Fueling a Global Health Crisis
The WHO says governments are letting harmful drinks stay too cheap, and the compounding health costs are now impossible to ignore.